AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Synoglim MV 1.3 Tablet PR

Prescription Icon
Prescription Required

Marketer

Synodic Lifesciences Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Synoglim MV 1.3 Tablet PR

Diabetase, a combination anti-diabetic medication, manages type 2 diabetes in adults by regulating blood glucose. Administered orally with food, Diabetase requires consistent daily dosing as prescribed by your physician; dosage adjustments may occur based on blood sugar monitoring. Continuous use is crucial; abrupt cessation can lead to dangerously elevated blood sugar, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. Diabetase complements a comprehensive diabetes management plan encompassing diet, exercise, and weight control, as recommended by your doctor. Hypoglycemia (low blood sugar) is a prevalent side effect; symptoms include sweating, lightheadedness, headache, and tremors. Prompt glucose intake (e.g., sugary foods or juice) is essential. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, visual disturbances, edema, bone fractures, upper respiratory infections, and weight gain. Diabetase is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should consult their physician before initiating treatment. Pregnant or lactating women should seek medical advice prior to use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Uses of Synoglim MV 1.3 Tablet PR

Managing type 2 diabetes

Major Benefits of Synoglim MV 1.3 Tablet PR:

Follow your doctor's instructions or consult the product label for usage guidelines. Administer Synoglim MV 1.3 Tablet PR on an empty stomach.

Common Side effects of Synoglim MV 1.3 Tablet PR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Synoglim MV 1.3 Tablet PR:

Follow your physician's instructions or refer to the product labeling for guidance. Administer Synoglim MV 1.3 Tablet PR on an empty stomach.

How Synoglim MV 1.3 Tablet PR works:

Synoglim MV 1.3 Tablet PR combines three distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Synoglim MV 1.3 Tablet PR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Synoglim MV 1.3 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Breastfeeding while taking Synoglim MV 1.3 Tablet PR is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyUNSAFE

Patients with kidney impairment should likely avoid Synoglim MV 1.3 Tablet PR due to potential safety concerns. Physician consultation is advised. The use of Synoglim MV 1.3 Tablet PR is contraindicated in those with severely compromised kidney function.

LiverLiverCAUTION

Patients with liver impairment should use Synoglim MV 1.3 Tablet PR cautiously, potentially requiring dosage modification. Consult a physician before use. A reduced initial dose is typically prescribed for individuals with mild to moderate hepatic dysfunction; the medication is contraindicated in those with severe liver disease.

What if you forget to take Synoglim MV 1.3 Tablet PR :

Forgetting a Synoglim MV 1.3 Tablet PR dose? Take it immediately if you remember. But, if your next dose is nearly due, omit the missed one and resume your usual dosing pattern. Never take two doses at once.

Facts to Know About Synoglim MV 1.3 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Synoglim MV 1.3 Tablet PR

Synoglim MV 1.3 Tablet PR combines glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This triple-drug therapy improves blood glucose control when coupled with diet and exercise. Glimepiride stimulates insulin release from the pancreas, metformin reduces liver glucose production and enhances insulin sensitivity, and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This combination is unsuitable for type 1 diabetes.
Synoglim MV 1.3 Tablet PR may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste perception, flatulence, abdominal pain, headache, skin rash, and respiratory infection.
Synoglim MV 1.3 Tablet PR is contraindicated in patients with allergies to its components or excipients, moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Synoglim MV 1.3 Tablet PR with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Synoglim MV 1.3 Tablet PR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Store this medication in its original, tightly sealed container, following the storage instructions on the label. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
Synoglim MV 1.3 Tablet PR
103
MRP 125
17% off